160 related articles for article (PubMed ID: 30661636)
1. Market Consolidation and Mortality in Patients Initiating Hemodialysis.
Erickson KF; Winkelmayer WC; Ho V; Bhattacharya J; Chertow GM
Value Health; 2019 Jan; 22(1):69-76. PubMed ID: 30661636
[TBL] [Abstract][Full Text] [Related]
2. Consolidation in the Dialysis Industry, Patient Choice, and Local Market Competition.
Erickson KF; Zheng Y; Winkelmayer WC; Ho V; Bhattacharya J; Chertow GM
Clin J Am Soc Nephrol; 2017 Mar; 12(3):536-545. PubMed ID: 27831510
[TBL] [Abstract][Full Text] [Related]
3. Association of Hospitalization and Mortality Among Patients Initiating Dialysis With Hemodialysis Facility Ownership and Acquisitions.
Erickson KF; Zhao B; Niu J; Winkelmayer WC; Bhattacharya J; Chertow GM; Ho V
JAMA Netw Open; 2019 May; 2(5):e193987. PubMed ID: 31099872
[TBL] [Abstract][Full Text] [Related]
4. Organizational Characteristics Associated with High Performance in Medicare's Comprehensive End-Stage Renal Disease Care Initiative.
Drewry KM; Trivedi AN; Wilk AS
Clin J Am Soc Nephrol; 2021 Oct; 16(10):1522-1530. PubMed ID: 34620648
[TBL] [Abstract][Full Text] [Related]
5. Effect of the ownership of dialysis facilities on patients' survival and referral for transplantation.
Garg PP; Frick KD; Diener-West M; Powe NR
N Engl J Med; 1999 Nov; 341(22):1653-60. PubMed ID: 10572154
[TBL] [Abstract][Full Text] [Related]
6. Temporal Analysis of Market Competition and Density in Renal Transplantation Volume and Outcome.
Adler JT; Yeh H; Markmann JF; Nguyen LL
Transplantation; 2016 Mar; 100(3):670-7. PubMed ID: 26574684
[TBL] [Abstract][Full Text] [Related]
7. Consolidation in dialysis Markets-Causes, consequences, and the role of policy.
Saeed MK; Ho V; Erickson KF
Semin Dial; 2020 Jan; 33(1):90-99. PubMed ID: 31930560
[TBL] [Abstract][Full Text] [Related]
8. A national study of efficiency for dialysis centers: an examination of market competition and facility characteristics for production of multiple dialysis outputs.
Ozgen H; Ozcan YA
Health Serv Res; 2002 Jun; 37(3):711-32. PubMed ID: 12132602
[TBL] [Abstract][Full Text] [Related]
9. Market Competition and Health Outcomes in Hemodialysis.
Erickson KF; Zheng Y; Ho V; Winkelmayer WC; Bhattacharya J; Chertow GM
Health Serv Res; 2018 Oct; 53(5):3680-3703. PubMed ID: 29468675
[TBL] [Abstract][Full Text] [Related]
10. For-profit status and industry evolution in health care markets: evidence from the dialysis industry.
Wilson NE
Int J Health Econ Manag; 2016 Dec; 16(4):297-319. PubMed ID: 27878689
[TBL] [Abstract][Full Text] [Related]
11. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
[TBL] [Abstract][Full Text] [Related]
12. Dialysis chains and placement on the waiting list for a cadaveric kidney transplant.
Zhang Y; Thamer M; Kshirsagar O; Cotter DJ; Schlesinger MJ
Transplantation; 2014 Sep; 98(5):543-51. PubMed ID: 24798304
[TBL] [Abstract][Full Text] [Related]
13. Impact of capitation on free-standing dialysis facilities: can you survive?
McMurray SD; Miller J
Am J Kidney Dis; 1997 Oct; 30(4):542-8. PubMed ID: 9328370
[TBL] [Abstract][Full Text] [Related]
14. Impact of Early Cannulation Grafts on Quality and Cost of Care for Patients With End-Stage Renal Disease.
Desai SS
Ann Vasc Surg; 2019 Oct; 60():203-210. PubMed ID: 31200049
[TBL] [Abstract][Full Text] [Related]
15. Bundled Payment Reform and Dialysis Facility Closures in ESKD.
Norouzi S; Zhao B; Awan A; Winkelmayer WC; Ho V; Erickson KF
J Am Soc Nephrol; 2020 Mar; 31(3):579-590. PubMed ID: 32019784
[TBL] [Abstract][Full Text] [Related]
16. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study.
Plantinga LC; Fink NE; Jaar BG; Sadler JH; Levin NW; Coresh J; Klag MJ; Powe NR
BMC Health Serv Res; 2007 Jan; 7():5. PubMed ID: 17212829
[TBL] [Abstract][Full Text] [Related]
17. Dialysis facility ownership and epoetin dosing in patients receiving hemodialysis.
Thamer M; Zhang Y; Kaufman J; Cotter D; Dong F; Hernán MA
JAMA; 2007 Apr; 297(15):1667-74. PubMed ID: 17440144
[TBL] [Abstract][Full Text] [Related]
18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of haemodialysis and peritoneal dialysis for patients with end-stage renal disease in Singapore.
Yang F; Lau T; Luo N
Nephrology (Carlton); 2016 Aug; 21(8):669-77. PubMed ID: 26566750
[TBL] [Abstract][Full Text] [Related]
20. Patient Health Outcomes following Dialysis Facility Closures in the United States.
Niu J; Saeed MK; Winkelmayer WC; Erickson KF
J Am Soc Nephrol; 2021 Oct; 32(10):2613-2621. PubMed ID: 34599037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
